DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $537,334,135 | +2.9% | 2,166,872 | -0.4% | 1.98% | +3.8% |
| Q2 2023 | $522,015,546 | -0.0% | 2,176,140 | +5.0% | 1.91% | -4.5% |
| Q1 2023 | $522,076,133 | -5.8% | 2,072,477 | -0.8% | 2.00% | -1.5% |
| Q4 2022 | $554,419,061 | +2.6% | 2,090,038 | -0.1% | 2.03% | -11.1% |
| Q3 2022 | $540,141,000 | +2.1% | 2,092,422 | +0.2% | 2.29% | +7.3% |
| Q2 2022 | $529,056,000 | -14.2% | 2,088,103 | -0.6% | 2.13% | +5.8% |
| Q1 2022 | $616,270,000 | -11.5% | 2,100,943 | -0.7% | 2.02% | -12.2% |
| Q4 2021 | $696,370,000 | +7.3% | 2,116,562 | -0.7% | 2.30% | -4.0% |
| Q3 2021 | $649,102,000 | +12.0% | 2,132,118 | -1.3% | 2.39% | +13.0% |
| Q2 2021 | $579,755,000 | +16.4% | 2,160,363 | -2.3% | 2.12% | -1.4% |
| Q1 2021 | $497,866,000 | +0.0% | 2,211,951 | -1.3% | 2.15% | -9.9% |
| Q4 2020 | $497,638,000 | +2.2% | 2,240,199 | -1.0% | 2.38% | -5.1% |
| Q3 2020 | $487,125,000 | +19.5% | 2,262,222 | -1.9% | 2.51% | +6.5% |
| Q2 2020 | $407,765,000 | +24.4% | 2,305,970 | -2.6% | 2.36% | +11.0% |
| Q1 2020 | $327,741,000 | -12.8% | 2,367,895 | -3.4% | 2.12% | +12.6% |
| Q4 2019 | $376,052,000 | +4.6% | 2,450,172 | -1.6% | 1.89% | -4.7% |
| Q3 2019 | $359,678,000 | +0.2% | 2,490,326 | -0.9% | 1.98% | -0.7% |
| Q2 2019 | $359,115,000 | +6.0% | 2,512,696 | -2.1% | 1.99% | +2.0% |
| Q1 2019 | $338,686,000 | +26.4% | 2,565,415 | -1.3% | 1.96% | +17.2% |
| Q4 2018 | $268,011,000 | -8.6% | 2,599,025 | -3.7% | 1.67% | +6.7% |
| Q3 2018 | $293,194,000 | +9.0% | 2,698,270 | -1.0% | 1.56% | +0.8% |
| Q2 2018 | $268,931,000 | -0.6% | 2,725,287 | -1.4% | 1.55% | +0.8% |
| Q1 2018 | $270,529,000 | +3.2% | 2,763,037 | -2.2% | 1.54% | +7.2% |
| Q4 2017 | $262,138,000 | +7.0% | 2,824,159 | -1.1% | 1.44% | +2.4% |
| Q3 2017 | $244,990,000 | +5.5% | 2,856,032 | +3.8% | 1.40% | +3.6% |
| Q2 2017 | $232,194,000 | -0.7% | 2,751,440 | +0.6% | 1.35% | -2.5% |
| Q1 2017 | $233,844,000 | +3.2% | 2,734,066 | -6.1% | 1.39% | +0.8% |
| Q4 2016 | $226,566,000 | -1.4% | 2,910,662 | -0.8% | 1.38% | -1.7% |
| Q3 2016 | $229,899,000 | -11.8% | 2,932,760 | +13.6% | 1.40% | -12.4% |
| Q2 2016 | $260,646,000 | +5.8% | 2,580,662 | -0.6% | 1.60% | +5.7% |
| Q1 2016 | $246,263,000 | +10.4% | 2,596,075 | +8.1% | 1.52% | +10.7% |
| Q4 2015 | $222,977,000 | +9.0% | 2,400,705 | +0.0% | 1.37% | +4.0% |
| Q3 2015 | $204,492,000 | +6.8% | 2,399,859 | +7.2% | 1.32% | +16.3% |
| Q2 2015 | $191,557,000 | +12.9% | 2,238,084 | +12.0% | 1.13% | +15.6% |
| Q1 2015 | $169,698,000 | +3.8% | 1,998,801 | +4.7% | 0.98% | +5.6% |
| Q4 2014 | $163,552,000 | -2.2% | 1,908,203 | -13.3% | 0.93% | -4.8% |
| Q3 2014 | $167,268,000 | +31.2% | 2,201,481 | +35.9% | 0.97% | +20.4% |
| Q2 2014 | $127,529,000 | +17.9% | 1,619,838 | +12.3% | 0.81% | +13.3% |
| Q1 2014 | $108,188,000 | -1.7% | 1,442,513 | +1.2% | 0.71% | -1.9% |
| Q4 2013 | $110,049,000 | +12.9% | 1,425,513 | +1.3% | 0.73% | +6.8% |
| Q3 2013 | $97,501,000 | +4.2% | 1,406,545 | +1.0% | 0.68% | +5.7% |
| Q2 2013 | $93,553,000 | – | 1,392,370 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |